Corcept Therapeutics Inc. (GB:0I3Q)

Corcept Therapeutics (0I3Q) Share Price & Analysis


0I3Q Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$17.97 - $30.10
Previous Close$23.14
Average Volume (3M)171.00
Market Cap
Enterprise Value$1.90B
Total Cash (Recent Filing)$465.06M
Total Debt (Recent Filing)$575.00K
Price to Earnings (P/E)N/A
Jul 27, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding101,577,897
10 Day Avg. Volume126
30 Day Avg. Volume171
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)4.51
Price to Sales (P/S)27.07
Price to Cash Flow (P/CF)23.00
P/FCF Ratio23.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.59
Enterprise Value/Gross Profit4.79
Enterprise Value/Ebitda17.71
Price Target Upside21.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5




What was Corcept Therapeutics Inc.’s price range in the past 12 months?
Corcept Therapeutics Inc. lowest share price was $17.97 and its highest was $30.09 in the past 12 months.
    What is Corcept Therapeutics Inc.’s market cap?
    Currently, no data Available
    When is Corcept Therapeutics Inc.’s upcoming earnings report date?
    Corcept Therapeutics Inc.’s upcoming earnings report date is Jul 27, 2023 which is in 52 days.
      How were Corcept Therapeutics Inc.’s earnings last quarter?
      Corcept Therapeutics Inc. released its earnings results on May 03, 2023. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.199 by -$0.059.
        Is Corcept Therapeutics Inc. overvalued?
        According to Wall Street analysts Corcept Therapeutics Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Corcept Therapeutics Inc. pay dividends?
          Corcept Therapeutics Inc. does not currently pay dividends.
          What is Corcept Therapeutics Inc.’s EPS estimate?
          Corcept Therapeutics Inc.’s EPS estimate is $0.15.
            How many shares outstanding does Corcept Therapeutics Inc. have?
            Currently, no data Available
            What happened to Corcept Therapeutics Inc.’s price movement after its last earnings report?
            Corcept Therapeutics Inc. reported an EPS of $0.14 in its last earnings report, missing expectations of $0.199. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Corcept Therapeutics Inc.?
              Among the largest hedge funds holding Corcept Therapeutics Inc.’s share is Aristeia Capital LLC. It holds Corcept Therapeutics Inc.’s shares valued at 11M.


                Corcept Therapeutics Stock Smart Score

                The Corcept Therapeutics Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Corcept Therapeutics Inc.

                Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Corcept Therapeutics
                Mersana Therapeutics
                Karyopharm Therapeutics
                Fate Therapeutics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis